![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/47 | |
A61P 25/00 | |||
A61P 25/28 |
(11) | Number of the document | 2588131 |
(13) | Kind of document | T |
(96) | European patent application number | 11799034.1 |
Date of filing the European patent application | 2011-06-25 | |
(97) | Date of publication of the European application | 2013-05-08 |
(45) | Date of publication and mention of the grant of the patent | 2019-08-14 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2011/041922 |
Date | 2011-06-25 |
(87) | Number | WO 2011/163647 |
Date | 2011-12-29 |
(30) | Number | Date | Country code |
201161476210 P | 2011-04-15 | US | |
201161435710 P | 2011-01-24 | US | |
201161442115 P | 2011-02-11 | US | |
358857 P | 2010-06-25 | US | |
387862 P | 2010-09-29 | US | |
360786 P | 2010-07-01 | US | |
201161495268 P | 2011-06-09 | US |
(72) |
NATOLI, Farah, US
ZHU, Gaozhong, US
TEREW, Jennifer, US
JIANG, Yuan, US
TSUNG, Jamie, US
SHAHROKH, Zahra, US
VERNAGLIA, Brian, US
PAN, Jing, US
PFEIFER, Richard, US
CALIAS, Pericles, US
|
(73) |
Shire Human Genetic Therapies, Inc.,
300 Shire Way, Lexington MA 02421,
US
|
(54) | METHODS AND COMPOSITIONS FOR CNS DELIVERY OF HEPARAN N-SULFATASE |
METHODS AND COMPOSITIONS FOR CNS DELIVERY OF HEPARAN N-SULFATASE |